Slideshows

Counsel patients and parents on how best to prepare--click through these slides for the latest on school-related health issues.

What is in your differential diagnosis for a thin brown line of parallel bands, regular in width that span nail fold to free nail edge?

A short slide show highlights results of 6 new clinical studies that look at death, risk of death, and cheating death.

Brief slideshow summaries highlight Pokémon’s potential for diabetes prevention and other noteworthy study findings.

Asthenia and developmental delay seem at odds with well-defined musculature in this 9-month-old. What Dx do you suspect?

ADHD: seen only in kids; boys are more impaired vs girls; only stimulants work. Myths or facts?

Scroll through the slides for an Affordable Care Act “study” and other Web articles of interest to primary care.

An acute outbreak on a formerly clear-complected young girl is suspicious for some notable features that are missing. Your Dx?

Recent research on the health of older persons uncovers news both good and sobering. See highlights of 10 studies in our slides.

More meeting highlights from ASCO in cancer prevention, diagnosis, and treatment--in case your patient asks.

Slide Show: Get top-line results of 10 new studies on the most common non-skin cancer among US men.

The first stage of this rash began at birth; it has twice changed distinctly in form. Are these changes the key to a diagnosis?

This brief slide show toplines key research from the 58th Annual Scientific Meeting of the American Headache Society, June 1-4, 2016.

New findings and guidelines translate into better awareness, understanding, and clinical decision making.

Find ASCO meeting highlights here, with an emphasis on primary care’s role in cancer management.

About 90% of asthma patients use rescue inhalers--perhaps its because nearly 60% weren't instructed at diagnosis on asthma triggers to avoid. More results, here.

Can you identify this acute widespread nodular rash on a neonate who is otherwise ready for discharge?

FDA is requiring a class labeling change that will allow many more diabetes patients to benefit from metformin.